孕早期孕妇生殖因素对产前筛查指标的影响
https://doi.org/10.47093/2218-7332.2020.11.3.37-46
摘要
简介
孕妇生殖因素对孕妇产前筛查中染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus),以及早产(PB)的风险指标的影响尚未得到充分研究。
目的
研究孕妇生殖因素对产前筛查中使用的Astraia Obstetrics 模板评估的染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus),以及早产(PB)风险指标的影响。
材料和方法
在接受产前筛查的11841名孕妇中,有18.53%的患者的检查结果为高风险(频率在1:100甚至更高)。将高风险的患者单独分为几个组,染色体异常-69例,子痫前症(PE)-66例,小于胎龄儿(SGA fetus)-48例,早产-52例。通过按年龄分层随机分组的方式从低危患者组中选择208名进行对照。
结果
在生殖器外疾病中,所有高危组常见为:高血压(AH)I和II级-31–47%,对照组为4.8%(p <0.05),下肢静脉曲张(VVLE)-17-30%,对照组为5.3%(p<0.05),有卵巢肿瘤病史-12-33%,对照组为3%(p<0.05)。在发生染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus)的高危组中,子宫肌瘤和缺铁性贫血相较对照组更常见,分别为:10-41%,对照组为1%(p<0.05),和10-17%,对照组为3%(p<0.05)。有妊娠史的初产妇在染色体异常(CA)(33%)和早产(35%)的高风险组更常见,对照组为17%(p<0.05)。
结论
将所有研究结果与动脉高血压,下肢静脉曲张,卵巢肿瘤病史之间建立关联。与对照组相比,在染色体异常(CA),子痫前症(PE),小于胎龄儿(SGA fetus)的高危亚组中,子宫肌瘤和缺铁性贫血(IDA)的发生率更高。
关于作者
P. M. Samchuk俄罗斯联邦
A. I. Ishchenko
俄罗斯联邦
E. L. Azoeva
参考
1. Livrinova V., Petrov I., Samardziski I., et al. Clinical importance of low level of PAPP-a in first trimester of pregnancy — an obstetrical dilemma in chromomally normal fetus. 2019; 7(9): 1475–79. https://doi.org/10.3889/oamjms.2019.384 PMID: 31198458
2. Акушерство: Национальное руководство. Под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова, В.Е. Радзинского. М.: ГЭОТАР-Медиа. 2019; 1080.
3. Радзинский В. Е. Акушерская агрессия, v. 2.0. М.: Издательство журнала StatusPraesens. 2017; 872.
4. Usta I.M., Zoorob D., Abu-Musa A., et al. Obstetric outcome of teenage pregnancies compared with adult pregnancies. 2008; 87(2): 178–83. https://doi.org/10.1080/00016340701803282 PMID: 18231885
5. Ciancimino L., Laganà A.S., Chiofalo B., et al. Would it be too late? A retrospective case-control analysis to evaluate maternalfetal outcomes in advanced maternal age. 2014; 290(6): 1109–14. https://doi.org/10.1007/s00404-014-3367-5 PMID: 25027820
6. Langley S. A Nutrition Screening Form for Female Infertility Patients. 2014; 75(4): 195–201. https://doi.org/10.3148/cjdpr-2014-024 PMID: 26067073
7. Диагностика и лечение сердечно-сосудистых заболеваний при беременности 2018. Национальные рекомендации. Российский кардиологический журнал. 2018; 3(155): 91–134. http://dx.doi.org/10.15829/1560-4071-2018-3-91-134
8. Стуклов Н.И. Железодефицитная анемия в практике гинеколога. Алгоритмы диагностики, профилактики и лечения. Акушерство и гинекология. 2016; 7: 99–104. http://doi.org/10.18565/aig.2016.7.99-104
9. Farkash E., Weintraub A.Y., Sergienko R., et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012; 162(1): 24–7. https://doi.org/10.1016/j.ejogrb.2012.01.024 PMID: 22381037
10. Matuszkiewicz-Rowińska J., Małyszko J., Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015; 11(1): 67–77. https://doi.org/10.5114/aoms.2013.39202 PMID: 25861291
11. Mason E., Chandra-Mouli V., Baltag V., et al. Preconception care: advancing from ‘important to do and can be done’ to ‘is being done and is making a difference’. Reproductive health. 2014; 11 (Suppl 3): S8. https://doi.org/10.1186/1742-4755-11-S3-S8 PMID: 25415261
12. Dean S.V., Imam A.M., Lassi Z.S., Bhutta Z.A. Importance of intervening in the preconception period to impact pregnancy outcomes. 2013; 74: 63–73. https://doi.org/10.1159/000348402 PMID: 23887104
13. Dean S.V., Lassi Z.S., Imam A.M., Bhutta Z.A. Preconception care: closing the gap in the continuum of care to accelerate improvements in maternal, newborn and child health. Reprod Health. 2014; 11(Suppl 3): S1. https://doi.org/10.1186/1742-4755-11-S3- S1 PMID: 25414942
14. Тихомиров А.Л., Сарсания С.И. Проблема железодефицитной анемии у женщин: пути решения. РМЖ. Мать и дитя. 2020; 1: 44–50. https://doi.org/10.32364/2618-8430-2020-3-1-44-50
15. O’Gorman N., Wright D., Poon L.C., et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017 Jun; 49(6): 751–5. https://doi.org/10.1002/uog.17399 PMID: 28067011
16. Panaitescu A.M., Baschat A.A., Akolekar R., et al. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound Obstet Gynecol. 2017 Sep; 50(3): 361–6. https://doi.org/10.1002/uog.17553 PMID: 28636133
17. Panaitescu A. M., Syngelaki A., Prodan N., et al. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2017 Aug; 50(2): 228–35. https://doi.org/10.1002/uog.17493 PMID: 28436175
18. Безнощенко Г.Б., Кравченко Е.Н., Цуканов Ю.Т. и др. Варикозная болезнь у беременных: особенности гестационного периода, флебогемодинамика малого таза и нижних конечностей. Российский вестник акушера-гинеколога. 2016; 16(3): 4–8. https://doi.org/10.17116/rosakush20161634-8
19. Cordina M., Marianna S., Fernandez M., et al. Maternal hemoglobin at 27-29 weeks’ gestation and severity of pre-eclampsia. J Matern Fetal Neonatal Med. 2015 Sep; 28(13): 1575–80. https://doi.org/10.3109/14767058.2014.961006 PMID: 25184521